organic l-carnitine [(3R)-3-Hydroxyoctadecanoyl]-L-carnitine Natural Factors, L-Carnitine 500 mg,

For patients who did not complete the treatment protocol, chart review was employed to identify reasons for discontinuing therapy and to analyze pertinent associations regarding demographics, medication type, and insurance

Inflammation control (TB-500): TB-500 is often promoted as an anti-inflammatory peptide that could ease chronic soreness or help manage overuse injuries

(3) removal of the Screening for SDOH measure beginning with the CY 2025 reporting period/CY 2027 payment determination

We adhere to established protocols, including those developed by the University of Kansas, which have been instrumental in this research

Bullard T, Ji M, An R, Trinh L, Mackenzie M, Mullen SP